The Europe fill finish pharmaceutical contract manufacturing market size is expected to reach USD 3.5 billion by 2030, expanding at a CAGR of 6.1%. The market is driven by factors such as the increasing demand for sterile injectable drugs, the rising prevalence of chronic diseases, and the growing focus on cost containment and efficiency by pharmaceutical companies. Additionally, advancements in technology and the increasing use of contract manufacturing by pharmaceutical companies are expected to drive market growth.
The Europe fill finish pharmaceutical contract manufacturing market is also characterized by a number of trends, such as the growing importance of regulatory compliance, the increasing use of single-use technology, and the rising adoption of advanced analytical and quality control systems. Additionally, there is a growing trend towards the use of contract manufacturing by small and mid-sized pharmaceutical companies, as well as by virtual biotech companies.
Germany dominated the market in 2022 owing to a strong base of biotechnology and pharmaceutical companies in the region. These companies are involved in drug discovery activities, which, in turn, led to the growth of the market in the region. The COVID-19 pandemic has had a significant impact, and one of the major impacts of the pandemic on the fill-finish contract manufacturing market in Europe has been an increased demand for COVID-19 vaccines and therapies. This has aided in increasing the demand for CMOs in the market since the fill-finish process requires advanced technology; thus, to reduce the cost, many Pharma and Biotech companies are more focused on outsourcing the fill-finish process, thereby boosting the overall market growth.
The Europe fill finish pharmaceutical contract manufacturing market is also characterized by a number of trends, such as the growing importance of regulatory compliance, the increasing use of single-use technology, and the rising adoption of advanced analytical and quality control systems. Additionally, there is a growing trend towards the use of contract manufacturing by small and mid-sized pharmaceutical companies, as well as by virtual biotech companies.
Germany dominated the market in 2022 owing to a strong base of biotechnology and pharmaceutical companies in the region. These companies are involved in drug discovery activities, which, in turn, led to the growth of the market in the region. The COVID-19 pandemic has had a significant impact, and one of the major impacts of the pandemic on the fill-finish contract manufacturing market in Europe has been an increased demand for COVID-19 vaccines and therapies. This has aided in increasing the demand for CMOs in the market since the fill-finish process requires advanced technology; thus, to reduce the cost, many Pharma and Biotech companies are more focused on outsourcing the fill-finish process, thereby boosting the overall market growth.
Europe Fill Finish Pharmaceutical Contract Manufacturing Market Report Highlights
- On the basis of product type, Sterile accounted for the largest revenue share of 52.2% in 2022. The rise of the sterile product category is being driven by the rising demand for biologics and biosimilars, as these goods need to be manufactured using sterile techniques in order to be safe and effective
- Based on the Molecule type, the small molecule segment dominated the market in 2022 with the largest share of 61.9% in 2022 and is anticipated to show lucrative growth over the forecast period
- Based on the End-use segment, the biopharmaceutical segment dominated the market and accounted for the largest revenue share of 54.9% in 2022. The increasing demand for biologics and biosimilars is driving the growth of the biopharmaceutical end-use segment. Due to the market for biologics and biosimilars experiencing rapid expansion, biopharmaceutical companies are the main consumers of fill-finish contract manufacturing services
- Germany dominated the Europe fill-finish pharmaceutical contract manufacturing market with a revenue share of over 22.7% in 2022, as well as expected to register the fastest rate with a CAGR of 6.5% over the forecast period. Germany's central location in Europe and well-developed transportation infrastructure make it an ideal location for pharmaceutical companies looking to distribute their products throughout Europe
Table of Contents
Chapter 1 Research Methodology & Scope1.1 Market Segmentation and Scope
1.2 Market Definitions
1.2.1 Molecule Type
1.2.2 Product Type
1.2.3 End - Use
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Information Analysis
1.4.2 Market Formulation & Data Visualization
1.4.3 Data Validation & Publishing
1.5 Research Scope And Assumptions
1.5.1 Commodity Flow Analysis
1.5.2 Top Down Market Estimation
1.5.3 Country Based Segment Share Calculation
1.5.4 Multivariate Analysis
1.5.5 Fill Finish Pharmaceutical Contract Manufacturing Market: Cagr Calculation
1.6 List Of Secondary Sources
1.7 Objectives
1.7.1 Objective - 1:
1.7.2 Objective - 2:
1.7.3 Objective - 3:
1.7.4 Objective - 4:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increasing Pharmaceutical R&D Expenses
3.2.1.2 Rising Technological Advancements In Fill - Finish Manufacturing Processes
3.2.1.3 Increasing Demand For Fill - Finish Outsourcing
3.2.2 Market Restraint Impact Analysis
3.2.2.1 Stringent Regulatory Issues
3.3 Industry Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel Analysis
3.4 Covid - 19 Impact On Fill - Finish Pharmaceutical Contract Manufacturing Market
3.5 Qualitative Analysis Of The Filling Application Capabilities Of Various Systems
3.5.1 Semi - Automated Mono - Block
3.5.2 High - Speed Filling Lines
3.6 Analysis of the Vision System for Automatic Filling Machines
Chapter 4 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Product Type Estimates & Trend Analysis
4.1 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market by Product Type: Key Takeaways
4.2 Product Type Movement Analysis & Market Share, 2022 & 2030
4.3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates & Forecast, By Service (USD Million)
4.3.1 Sterile
4.3.1.1 Prefilled Syringes
4.3.1.2 Vials
4.3.1.3 Cartridges
4.3.1.4 Others
4.3.2 Non - Sterile
Chapter 5 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Molecule Type Estimates & Trend Analysis
5.1 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market by Molecule Type: Key Takeaways
5.2 Molecule Type Movement Analysis & Market Share, 2022 & 2030
5.3 Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates & Forecast, By Molecule Type (USD Million)
5.3.1 Small Molecules
5.3.2 Large Molecules
Chapter 6 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: End - Use Estimates & Trend Analysis
6.1 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market By End - Use: Key Takeaways
6.2 End - Use Movement Analysis & Market Share, 2022 & 2030
6.3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates & Forecast, By Ens - Use (USD Million)
6.3.1 Biopharmaceutical Companies
6.3.2 Pharmaceutical Companies
Chapter 7 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Country Analysis
7.1 Europe
7.1.1 Regulatory Framework
7.1.2 Competitive Scenario
7.1.3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.8 U.K.
7.1.8.1 Key Country Dynamics
7.1.8.2 U.K. Fill - Finish Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
7.1.9 Germany
7.1.9.1 Key Country Dynamics
7.1.9.2 Germany Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.10 France
7.1.10.1 Key Country Dynamics
7.1.10.2 France Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.11 Italy
7.1.11.1 Key Country Dynamics
7.1.11.2 Italy Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.12 Spain
7.1.12.1 Key Country Dynamics
7.1.12.2 Spain Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.13 Denmark
7.1.13.1 Key Country Dynamics
7.1.13.2 Denmark Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.14 Sweden
7.1.14.1 Key Country Dynamics
7.1.14.2 Sweden Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.15 Norway
7.1.15.1 Key Country Dynamics
7.1.15.2 Norway Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.16 Switzerland
7.1.16.1 Key Country Dynamics
7.1.16.2 Switzerland Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.17 Belgium
7.1.17.1 Belgium Fill - Finish Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
7.1.18 Rest of Europe
7.1.18.1 Rest of Europe Fill - Finish Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Overview
8.1.1 Thermo Fisher Scientific, Inc.
8.1.2 Sartorius AG
8.1.3 Boehringer Ingelheim
8.1.4 Catalent, Inc.
8.1.5 Societal CDMO (Recro Pharma, Inc)
8.1.6 Baxter BioPharma Solutions
8.1.7 Eurofins Scientific
8.1.8 Symbiosis Pharmaceutical Service
8.1.9 MabPlex International Co. Ltd.
8.1.10 Recipharm AB
8.1.11 Fresenius Kabi Contract Manufacturing
8.1.12 Lonza
8.2 Financial Performance
8.3 Services Benchmarking
8.4 Strategy Mapping
8.4.1.1 Service Launches/Upgrades
8.4.1.2 Mergers/Acquisitions/Joint Ventures
8.4.1.3 Facility/Capacity Expansion
8.4.1.4 Partnerships & Collaborations
8.4.1.5 Regional Expansion
8.4.1.6 Others
8.5 Company Position Heat Map Analysis
Chapter 9 Key Takeaways
List of Tables
Table 1 Molecule type segment definition
Table 2 Product type segment definition
Table 3 End - use segment definition
Table 4 List of secondary sources
Table 5 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market revenue estimates and forecast, by product type, 2018 - 2030 (USD Millions)
Table 6 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market revenue estimates and forecast, by molecule type, 2018 - 2030 (USD Million)
Table 7 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market revenue estimates and forecast, by End - use, 2018 - 2030 (USD Million)
Table 8 Company profiles: Company overview
Table 9 Company profiles: Financial performance
Table 10 Company profiles: Services benchmarking
Table 11 Key companies initiating service launches/upgrades.
Table 12 Key companies initiating mergers/acquisitions/joint ventures.
Table 13 Key companies initiating facility/capacity expansion.
Table 14 Key companies initiating partnerships & collaborations
Table 15 Key companies initiating regional expansion.
Table 16 Key companies initiating other strategies.
List of Figures
Fig. 1 Fill - Finish Pharmaceutical Contract Manufacturing Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation And Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Commodity flow analysis
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Global Fill Finish Pharmaceutical Contract Manufacturing Market Value, 2022 (USD Million)
Fig. 13 Healthcare CDMO Market Value, 2022 (USD Million)
Fig. 14 Porter’s five forces analysis
Fig. 15 PEST Analysis
Fig. 16 Fill - finish pharmaceutical contract manufacturing market, by product type: Key takeaways
Fig. 17 Fill - finish pharmaceutical contract manufacturing market, by product type: market share, 2022 & 2030
Fig. 18 Sterile market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 19 Prefilled syringes market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 20 Vials market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 21 Cartridges market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 23 Non - sterile market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 24 Fill - finish pharmaceutical contract manufacturing market, by Molecule type: Key takeaways 61
Fig. 25 Fill - finish pharmaceutical contract manufacturing market, by molecule type: market share, 2022 & 2030
Fig. 26 Small molecules market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 27 Large Molecules market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 28 Fill - finish pharmaceutical contract manufacturing market, by end - use: Key takeaways
Fig. 29 Fill - finish pharmaceutical contract manufacturing market, by end - use: market share, 2022 & 2030
Fig. 30 Biopharmaceutical companies market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 31 Pharmaceutical companies market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 32 Europe fill - finish pharmaceutical contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 Denmark fill - finish pharmaceutical contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 Sweden fill - finish pharmaceutical contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Key strategic initiatives by market players
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Boehringer Ingelheim
- Catalent, Inc.
- Societal CDMO (Recro Pharma, Inc)
- Baxter BioPharma Solutions
- Eurofins Scientific
- Symbiosis Pharmaceutical Service
- MabPlex International Co. Ltd.
- Recipharm AB
- Fresenius Kabi Contract Manufacturing
- Lonza
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 122 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.2 Billion |
| Forecasted Market Value ( USD | $ 3.5 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 12 |
